Medicare has started covering obesity drugs for the first time – and companies like Walmart and CVS Health are playing an ...

The move could unlock millions of new patients for Novo Nordisk and Eli Lilly and expand access to medications that were ...

The study reveals obesity's role in polypharmacy, indicating that reducing obesity may lower medication burden and enhance ...

Questions are swirling over Donald Trump’s health after a bombshell report revealed a mystery man was getting unprecedented ...

The Regional Obesity Management Service (ROMS) is expected to begin rolling out in early autumn 2026.

Many seniors may be unaware of the landmark coverage shift starting on July 1, with limited advertising seen from the ...

Body composition and obesity-related complications differ between men and women, but incretin-based medications confer benefits among all adults, according to a speaker at the Heart in Diabetes CME ...

In 1970, about 1 in 20 children were affected by obesity; today, it's 1 in 5. Dr. Jonathan LaPook looks at programs aimed at ...

Obesity could be associated with a distinct molecular process driving the transition from an early-stage, premalignant breast ...

Genetic factors primarily explain the link between parental and childhood BMI, with maternal obesity impacting birth weight ...

It might seem like semantics. But whether a health condition qualifies as a disease can have a huge impact on patient experiences and treatment options.

Who got exclusive access to Eli Lilly's highly anticipated obesity candidate? And why are drugmakers spending so much on ...